Global Menopausal Hot Flashes Drug Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Menopausal Hot Flashes Drug Market Overview

1.1 Menopausal Hot Flashes Drug Definition

1.2 Global Menopausal Hot Flashes Drug Market Size Status and Outlook (2019-2032)

1.3 Global Menopausal Hot Flashes Drug Market Size Comparison by Region (2019-2032)

1.4 Global Menopausal Hot Flashes Drug Market Size Comparison by Type (2019-2032)

1.5 Global Menopausal Hot Flashes Drug Market Size Comparison by Application (2019-2032)

1.6 Global Menopausal Hot Flashes Drug Market Size Comparison by Sales Channel (2019-2032)

1.7 Menopausal Hot Flashes Drug Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Menopausal Hot Flashes Drug Market Snapshot

2.2 Global Menopausal Hot Flashes Drug Market Volume & Revenue (2019-2025)

2.3 Global Menopausal Hot Flashes Drug Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Menopausal Hot Flashes Drug Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Menopausal Hot Flashes Drug Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Menopausal Hot Flashes Drug Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Menopausal Hot Flashes Drug Market Segment Analysis by Player

3.1 Global Menopausal Hot Flashes Drug Sales and Market Share by Player (2023-2025)

3.2 Global Menopausal Hot Flashes Drug Revenue and Market Share by Player (2023-2025)

3.3 Global Menopausal Hot Flashes Drug Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Menopausal Hot Flashes Drug Market Segment Analysis by Type

4.1 Global Menopausal Hot Flashes Drug Market by Type

4.1.1 Hormonal Medicines

4.1.2 Non-Hormonal Medicines

4.1.3 Complementary Alternative Medicines

4.2 Global Menopausal Hot Flashes Drug Sales and Market Share by Type (2019-2025)

4.3 Global Menopausal Hot Flashes Drug Revenue and Market Share by Type (2019-2025)

4.4 Global Menopausal Hot Flashes Drug Average Price by Type (2019-2025)

4.5 Leading Players of Menopausal Hot Flashes Drug by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Menopausal Hot Flashes Drug Market Segment Analysis by Application

5.1 Global Menopausal Hot Flashes Drug Market by Application

5.1.1 Hospital Pharmacies

5.1.2 Retail Pharmacies

5.1.3 Online Pharmacies

5.2 Global Menopausal Hot Flashes Drug Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Menopausal Hot Flashes Drug by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Menopausal Hot Flashes Drug Market Segment Analysis by Sales Channel

6.1 Global Menopausal Hot Flashes Drug Market by Sales Channel

6.1.1 Global Menopausal Hot Flashes Drug Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Menopausal Hot Flashes Drug Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Menopausal Hot Flashes Drug Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Menopausal Hot Flashes Drug by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Menopausal Hot Flashes Drug Market Segment Analysis by Region

7.1 Global Menopausal Hot Flashes Drug Market Size and CAGR by Region (2019-2032)

7.2 Global Menopausal Hot Flashes Drug Sales and Market Share by Region (2019-2025)

7.3 Global Menopausal Hot Flashes Drug Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Menopausal Hot Flashes Drug Market Share by Type

7.4.3 North America Menopausal Hot Flashes Drug Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Menopausal Hot Flashes Drug Market Share by Type

7.5.3 Europe Menopausal Hot Flashes Drug Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Menopausal Hot Flashes Drug Market Share by Type

7.6.3 Asia-Pacific Menopausal Hot Flashes Drug Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Menopausal Hot Flashes Drug Market Share by Type

7.7.3 South America Menopausal Hot Flashes Drug Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Menopausal Hot Flashes Drug Market Share by Type

7.8.3 Middle East & Africa Menopausal Hot Flashes Drug Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Menopausal Hot Flashes Drug Players

8.1 Allergan

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Bayer

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Besins Healthcare

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Endoceutics

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Fervent Pharmaceuticals

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 GlaxoSmithKline

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Hisamitsu Pharmaceutical

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 iHealth Labs

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Merck

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Millendo Therapeutics

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Mithra Pharmaceuticals

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 Mitsubishi Tanabe Pharma

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Mylan

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

8.14 Nerre Therapeutics

8.14.1 Company Snapshot

8.14.2 Product/Service Offered

8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.14.4 Recent Developments

8.15 Novartis

8.15.1 Company Snapshot

8.15.2 Product/Service Offered

8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.15.4 Recent Developments

8.16 Novo Nordisk

8.16.1 Company Snapshot

8.16.2 Product/Service Offered

8.16.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.16.4 Recent Developments

8.17 Ogeda

8.17.1 Company Snapshot

8.17.2 Product/Service Offered

8.17.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.17.4 Recent Developments

8.18 Pfizer

8.18.1 Company Snapshot

8.18.2 Product/Service Offered

8.18.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.18.4 Recent Developments

8.19 Pherin Pharmaceuticals

8.19.1 Company Snapshot

8.19.2 Product/Service Offered

8.19.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.19.4 Recent Developments

8.20 Teva Pharmaceutical

8.20.1 Company Snapshot

8.20.2 Product/Service Offered

8.20.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.20.4 Recent Developments

8.21 TherapeuticsMD

8.21.1 Company Snapshot

8.21.2 Product/Service Offered

8.21.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.21.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Menopausal Hot Flashes Drug

9.1 Industrial Chain of Menopausal Hot Flashes Drug

9.2 Upstream of Menopausal Hot Flashes Drug

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Menopausal Hot Flashes Drug

9.3.1 Leading Distributors/Dealers of Menopausal Hot Flashes Drug

9.3.2 Leading Consumers of Menopausal Hot Flashes Drug

Chapter 10. Global Menopausal Hot Flashes Drug Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Menopausal Hot Flashes Drug Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Menopausal Hot Flashes Drug Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Menopausal Hot Flashes Drug (2026-2032)

11.1 Global Menopausal Hot Flashes Drug Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Menopausal Hot Flashes Drug Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Menopausal Hot Flashes Drug Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Menopausal Hot Flashes Drug Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Menopausal Hot Flashes Drug Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Menopausal Hot Flashes Drug Import-Export (2019-2025)

12.2 Europe Menopausal Hot Flashes Drug Import-Export (2019-2025)

12.3 Asia Pacific Menopausal Hot Flashes Drug Import-Export (2019-2025)

12.4 South America Menopausal Hot Flashes Drug Import-Export (2019-2025)

12.5 Middle East & Africa Menopausal Hot Flashes Drug Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Menopausal Hot Flashes Drug Demand-Supply (2019-2025)

13.2 Europe Menopausal Hot Flashes Drug Demand-Supply (2019-2025)

13.3 Asia Pacific Menopausal Hot Flashes Drug Demand-Supply (2019-2025)

13.4 South America Menopausal Hot Flashes Drug Demand-Supply (2019-2025)

13.5 Middle East & Africa Menopausal Hot Flashes Drug Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources